0
Meta-analysis |

Increased Genetic Vulnerability to Smoking at CHRNA5 in Early-Onset Smokers

Sarah M. Hartz, MD, PhD; Susan E. Short, PhD; Nancy L. Saccone, PhD; Robert Culverhouse, PhD; LiShiun Chen, MD, MPH, ScD; Tae-Hwi Schwantes-An, MS; Hilary Coon, PhD; Younghun Han, PhD; Sarah H. Stephens, PhD; Juzhong Sun, MPH, MSc; Xiangning Chen, PhD; Francesca Ducci, MD, PhD; Nicole Dueker, PhD; Nora Franceschini, MD, MPH; Josef Frank, MSc; Frank Geller, MSc; Daniel Gubjartsson, PhD; Nadia N. Hansel, MD, MPH; Chenhui Jiang, MA; Kaisu Keskitalo-Vuokko, PhD; Zhen Liu, PhD; Leo-Pekka Lyytikäinen, MD; Martha Michel, PhD; Rajesh Rawal, Dr Sc Hum; Albert Rosenberger, MS; Paul Scheet, PhD; John R. Shaffer, PhD; Alexander Teumer, PhD; John R. Thompson, PhD; Jacqueline M. Vink, PhD; Nicole Vogelzangs, PhD; Angela S. Wenzlaff, MPH; William Wheeler, PhD; Xiangjun Xiao, MS; Bao-Zhu Yang, PhD; Steven H. Aggen, PhD; Anthony J. Balmforth, PhD; Sebastian E. Baumeister, PhD; Terri Beaty, PhD; Siiri Bennett, MD; Andrew W. Bergen, PhD; Heather A. Boyd, PhD; Ulla Broms, PhD; Harry Campbell, MD; Nilanjan Chatterjee, PhD; Jingchun Chen, MD, PhD; Yu-Ching Cheng, PhD; Sven Cichon, PhD; David Couper, PhD; Francesco Cucca, MD; Danielle M. Dick, PhD; Tatiana Foroud, PhD; Helena Furberg, MSPH, PhD; Ina Giegling, PhD; Fangyi Gu, ScD; Alistair S. Hall, PhD; Jenni Hällfors, MSc; Shizhong Han, PhD; Annette M. Hartmann, PhD; Caroline Hayward, PhD; Kauko Heikkilä, Phil Lic; John K. Hewitt, PhD; Jouke Jan Hottenga, PhD; Majken K. Jensen, PhD; Pekka Jousilahti, MD, PhD; Marika Kaakinen, MSc; Steven J. Kittner, MD, MPH; Bettina Konte, MSc; Tellervo Korhonen, PhD; Maria-Teresa Landi, PhD; Tiina Laatikainen, MD, PhD; Mark Leppert, PhD; Steven M. Levy, DDS, MPH; Rasika A. Mathias, ScD; Daniel W. McNeil, PhD; Sarah E. Medland, PhD; Grant W. Montgomery, PhD; Thomas Muley, PhD; Tanda Murray, PhD; Matthias Nauck, MD; Kari North, PhD; Michele Pergadia, PhD; Ozren Polasek, MD, MPH, PhD; Erin M. Ramos, PhD; Samuli Ripatti, PhD; Angela Risch, PhD; Ingo Ruczinski, PhD; Igor Rudan, MD, MPH, PhD; Veikko Salomaa, MD, PhD; David Schlessinger, PhD; Unnur Styrkársdóttir, PhD; Antonio Terracciano, PhD; Manuela Uda, PhD; Gonneke Willemsen, PhD; Xifeng Wu, MD, PhD; Goncalo Abecasis, DPhil; Kathleen Barnes, PhD; Heike Bickeböller, PhD; Eric Boerwinkle, PhD; Dorret I. Boomsma, PhD; Neil Caporaso, MD; Jubao Duan, PhD; Howard J. Edenberg, PhD; Clyde Francks, DPhil; Pablo V. Gejman, MD; Joel Gelernter, MD; Hans Jörgen Grabe, MD; Hyman Hops, PhD; Marjo-Riitta Jarvelin, MD, MSc, PhD; Jorma Viikari, MD, PhD; Mika Kähönen, MD, PhD; Kenneth S. Kendler, MD; Terho Lehtimäki, MD, PhD; Douglas F. Levinson, MD; Mary L. Marazita, PhD; Jonathan Marchini, BSc, DPhil; Mads Melbye, MD, DMSc; Braxton D. Mitchell, PhD, MPH; Jeffrey C. Murray, MD; Markus M. Nöthen, PhD; Brenda W. Penninx, PhD; Olli Raitakari, MD, PhD; Marcella Rietschel, MD; Dan Rujescu, PhD; Nilesh J. Samani, MD; Alan R. Sanders, MD; Ann G. Schwartz, PhD; Sanjay Shete, PhD; Jianxin Shi, PhD; Margaret Spitz, MD; Kari Stefansson, MD, PhD; Gary E. Swan, PhD; Thorgeir Thorgeirsson, PhD; Henry Völzke, MD; Qingyi Wei, MD, PhD; H.-Erich Wichmann, MD, PhD; Christopher I. Amos, PhD; Naomi Breslau, PhD; Dale S. Cannon, PhD; Marissa Ehringer, PhD; Richard Grucza, PhD; Dorothy Hatsukami, PhD; Andrew Heath, DPhil; Eric O. Johnson, PhD; Jaakko Kaprio, MD, PhD; Pamela Madden, PhD; Nicholas G. Martin, PhD; Victoria L. Stevens, PhD; Jerry A. Stitzel, PhD; Robert B. Weiss, PhD; Peter Kraft, PhD; Laura J. Bierut, MD
Arch Gen Psychiatry. 2012;69(8):854-860. doi:10.1001/archgenpsychiatry.2012.124.
Text Size: A A A
Published online

Context  Recent studies have shown an association between cigarettes per day (CPD) and a nonsynonymous single-nucleotide polymorphism in CHRNA5, rs16969968.

Objective  To determine whether the association between rs16969968 and smoking is modified by age at onset of regular smoking.

Data Sources  Primary data.

Study Selection  Available genetic studies containing measures of CPD and the genotype of rs16969968 or its proxy.

Data Extraction  Uniform statistical analysis scripts were run locally. Starting with 94 050 ever-smokers from 43 studies, we extracted the heavy smokers (CPD >20) and light smokers (CPD ≤10) with age-at-onset information, reducing the sample size to 33 348. Each study was stratified into early-onset smokers (age at onset ≤16 years) and late-onset smokers (age at onset >16 years), and a logistic regression of heavy vs light smoking with the rs16969968 genotype was computed for each stratum. Meta-analysis was performed within each age-at-onset stratum.

Data Synthesis  Individuals with 1 risk allele at rs16969968 who were early-onset smokers were significantly more likely to be heavy smokers in adulthood (odds ratio [OR] = 1.45; 95% CI, 1.36-1.55; n = 13 843) than were carriers of the risk allele who were late-onset smokers (OR = 1.27; 95% CI, 1.21-1.33, n = 19 505) (P = .01).

Conclusion  These results highlight an increased genetic vulnerability to smoking in early-onset smokers.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure 1. Odds ratios (ORs) for heavy vs light smoking and rs16969968 A allele across studies where individuals are stratified by age at onset of regular smoking (AOS) of 16 years or younger vs older than 16 years. The P value for the difference between early onset and late onset is P = .01, based on 33 348 heavy and light smokers. The studies are grouped by continent to allow for cross-cultural comparisons. NA indicates not available.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 2. Meta-analysis of the association between the rs16969968 genotype and heavy (cigarettes per day [CPD] >20) vs light (CPD ≤10) smoking, stratified by early-onset (age at onset ≤16 years) and late-onset (onset >16 years) smoking. Odds ratios (ORs) are given relative to late-onset smokers with the GG genotype. Effect of the interaction between the rs16969968 A allele and early-onset smoking on risk of heavy smoking: OR = 1.16, n = 36 936, P = .01.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
Jobs
JAMAevidence.com